The effect of recombinant human TSH on 123I thyroid uptake after intravenous iodide contrast agent

Nuclear Medicine Communications

Volumn 31, Issue 4, 2010, Pages 315-319

  Resende, Monique ^a   Corbo, Rossana ^a   Vaisman, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Computed tomography; Contrast agent; Iodine isotopes; Iodine uptake; Recombinant human thyroid stimulating hormone; Thyroid gland

Indexed keywords

IODINE 123; IODINE 131; MEGLUMINE IOXITALAMATE; RECOMBINANT THYROTROPIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODIDE; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; THYROTROPIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG EXPOSURE; DRUG UPTAKE; FEMALE; GOITER; HUMAN; ISOTOPE LABELING; MALE; SINGLE DRUG DOSE; THYROID CANCER; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; MIDDLE AGED; RADIOGRAPHY; THYROID GLAND; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; BIOLOGICAL TRANSPORT; CONTRAST MEDIA; FEMALE; HUMANS; IODIDES; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THYROID GLAND; THYROTROPIN; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77954504920     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283355c8b     Document Type: Article

References (26)

1. Amdur RJ, Mazzaferri EL. Using rhTSH prior to I-131 therapy. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. New York: Springer Science + Business Media; 2005. pp. 239-246.
2. Amdur RJ, Mazzaferri EL. Recombinant human TSH: background information and standard protocol. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. New York: Springer Science+ Business Media; 2005. pp. 233-238.
3. Diário Oficial da União no 236, 12/11/06, p. 31. Resolução RE no 4034, 12/08/06.
4. Graf H, Paz-Filho G. Uso do TSH recombinante no câncer diferenciado de tireóide. Arq Bras Endocrinol Metabol 2007;51:806-812.
5. Lippi F, Capezzone M, Angelini F, Taddei D, Molinaro E, Pinchera A, et al. Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol 2001;144:5-11.
6. Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Relat Cancer 2005;12:49-64. (Pubitemid 40477087)
7. Albino CC, Mesa CO, Olandoski M, Ueda CE, Woellner LC, Goedert CA, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 2005;90:2775-2780.
8. 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 2005;90:79-83.
9. Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, et al. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroidstimulating hormone. J Nucl Med 2004;45:626-633.
10. Pedersen-Bjergaard U, Kirkegaard C. Serum TSH and the response to radioiodine treatment of toxic multinodular goitre. Eur J Endocrinol 1997;137:365-369.
11. 123I uptake in iodide treated normal subjects. J Clin Endocrinol Metab 2001;86:437-440.
12. Ramirez L, Braverman LE, White B, Emerson CH. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 1997;82:2836-2839.
13. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 2001;86:1660-1664.
14. Amdur RJ, Mazzaferri EL. Intravenous iodinated contrast effects iodine uptake for months. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. New York: Springer Science + Business Media; 2005. pp. 211-213.
15. Mazzaferri EL, Amdur RJ. Thyroid and parathyroid physiology. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. New York: Springer Science + Business Media; 2005. pp. 7-17.
16. Meios de diagnóstico. Preparaçōes radiofarmacêuticas (radiofá rmacos). Avaiable from: Formulário Hospitalar Nacional de Medicamentos URL: http://www.infarmed. pt. [Accessed on 20 April 2006]
17. Spate VL, Morris JS, Nichols TA, Baskett CK, Mason MM, Horsman TL, et al. Longitudinal study of iodine in toenails following IV administration of an iodine-containing contrast agent. J Radioanal Nucl Chem 1998;236:71-76.
18. Braverman LE, Ingbar SH. Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 1963;42:1216-1231.
19. Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999;140:3404-3410.
20. Golbert L, Wajner SM, Rocha AP, Maia AL, Gross JL. Carcinoma diferenciado de tireó ide: avaliação inicial e acompanhamento. Arq Bras Endocrinol Metabol 2005;49:701-710.
21. Graf H. Uso do TSH Recombinante no Câncer Diferenciado de Tireóide. Arq Bras Endocrinol Metab 2007;51:1555-1556.
22. Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). J Clin Endocrinol Metab 1994;78:188-196.
23. Resende M, Corbo R, Vaisman M. Indicaçōes para o uso do TSH Recombinante Humano. Rev Soc Bras Clin Med 2008;6:34-39.
24. Thyrogen TSH Recombinante. [Monografia de Produto]. Avaiable from http://www.thyrogen.com.br. [Accessed on 20 April 2006]
25. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 1997;138:2227-2232.
26. Weiss SJ, Philp NJ, Ambesi-Impiombato FS, Grollman EF. Thyrotropinstimulated iodide transport mediated by adenosine 3′, 5′-monophosphate and dependent on protein synthesis. Endocrinology 1984;114:1099-1107.